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Abstract 
Background: Malaria, caused by Plasmodium parasites, is a major global public health problem. To assist an under-
standing of malaria pathogenesis, including drug resistance, there is a need for the timely detection of underlying 
genetic mutations and their spread. With the increasing use of whole-genome sequencing (WGS) of Plasmodium 
DNA, the potential of deep learning models to detect loci under recent positive selection, historically signals of drug 
resistance, was evaluated.
Methods: A deep learning-based approach (called “DeepSweep”) was developed, which can be trained on haplotypic 
images from genetic regions with known sweeps, to identify loci under positive selection. DeepSweep software is 
available from https:// github. com/ WDee/ Deeps weep.
Results: Using simulated genomic data, DeepSweep could detect recent sweeps with high predictive accuracy (areas 
under ROC curve > 0.95). DeepSweep was applied to Plasmodium falciparum (n = 1125; genome size 23 Mbp) and Plas-
modium vivax (n = 368; genome size 29 Mbp) WGS data, and the genes identified overlapped with two established 
extended haplotype homozygosity methods (within-population iHS, across-population Rsb) (~ 60–75% overlap of hits 
at P < 0.0001). DeepSweep hits included regions proximal to known drug resistance loci for both P. falciparum (e.g. pfcrt, 
pfdhps and pfmdr1) and P. vivax (e.g. pvmrp1).
Conclusion: The deep learning approach can detect positive selection signatures in malaria parasite WGS data. Fur-
ther, as the approach is generalizable, it may be trained to detect other types of selection. With the ability to rapidly 
generate WGS data at low cost, machine learning approaches (e.g. DeepSweep) have the potential to assist parasite 
genome-based surveillance and inform malaria control decision-making.
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Background
Malaria, caused by Plasmodium parasites, is a major 
global health burden, with an estimated 229 million cases 
and 409,000 deaths in 2019 alone [1]. Plasmodium fal-
ciparum causes almost half of all malaria cases, and the 
majority of deaths are children in sub-Saharan Africa; 
Plasmodium vivax accounts for 65% of malaria cases in 
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combination of case management using diagnosis and 
treatment, and prevention using insecticide-treated nets, 
indoor residual spraying, and intermittent preventive 
treatment.
Resistance to anti-malarial medicines is a threat to the 
global efforts to control and eliminate malaria. Resist-
ance originates from Plasmodium genetic mutations that 
increase in frequency over time and “sweep” through 
populations. During the past fifty years, several first-line 
treatments for P. falciparum malaria, including chloro-
quine and sulfadoxine-pyrimethamine (SP), have been 
rolled-out and then subsequently replaced due to the 
emergence of resistance. Recently, resistance to arte-
misinin has been reported in the form of delayed parasite 
clearance in Southeast Asia, posing a threat to the cur-
rent first-line artemisinin-based combination therapy [2, 
3]. For P. vivax, the spread of resistance to chloroquine, 
primaquine, mefloquine, and SP has been reported in 
various regions of the world [4, 5]. The underlying muta-
tions causing resistance for P. vivax are less well defined 
than for P. falciparum [4–6].
Protecting and monitoring the efficacy of antimalarial 
treatments is a top priority for malaria endemic countries. 
There is a need to not only continuously monitor for drug 
resistance, which includes clinical reporting, but also to 
screen the parasite genome for known resistance muta-
tions (e.g. in P. falciparum: pfcrt (PF3D7_0709000), pfd-
hfr (PF3D7_0417200), pfdhps (PF3D7_0810800), pfmdr1 
(PF3D7_0523000), and pfkelch13 (PF3D7_1343700) 
[3]) and to identify potentially novel loci under puta-
tive positive selection. These insights are being facili-
tated by the characterization of genomic variation using 
whole-genome sequencing (WGS) across many Plas-
modium isolates, and the subsequent application of 
statistical and population genomics methods to detect 
sweeps. In particular, sweeps can be identified through 
statistical approaches considering population differen-
tiation, site-frequency spectra, or linkage disequilibrium 
and extended haplotype homozygosity (e.g. the within 
population integrated haplotype score (iHS), and the 
between population ratio (Rsb)) [7]. Whilst these meth-
ods have been developed for the human genome [8], they 
have been applied to Plasmodium and identified known 
genetic mutations contributing to drug resistance [9, 10]. 
Recently tools have been developed for the efficient com-
putation of these statistics from WGS libraries, such as 
REHH, SweeD and OmegaPlus [11–13], but they require 
parameter optimization and their results are sensitive to 
the SNPs included, population definition, and to the sta-
tistical significance thresholds used to make inferences.
In recent years, researchers have explored the possibil-
ity of augmenting traditional approaches to the detection 
of selective sweeps with machine learning methods [14]. 
To date, sweep detection algorithms have been applied to 
pre-calculated population genetic statistics (e.g. Tajima’s 
D, Fay and Wu’s H) [7]. Gradient boosted decision trees 
and random tree classifiers have been trained on simu-
lated data and applied to human 1000 Genomes Project 
data [15]. However, these methods do not solve the chal-
lenge of defining and calculating the population genetic 
statistics used as predictors of selection, a task which can 
be complex and time-consuming, especially when there 
are multiple sub-populations for cross-comparison. Deep 
(machine) learning methods may provide a viable alter-
native, and allow algorithms to learn through a hierar-
chy of features, where their definition and relationships 
can be inferred by the algorithm rather than externally 
defined [16]. The application of neural networks and deep 
learning has been explored within population genet-
ics [17–19]. More generally, these methods are gaining 
traction in healthcare and biomedical settings, where 
enormous amounts of data are being generated, which 
contain extremely valuable signals and information, at a 
pace far surpassing what “traditional” methods of analy-
sis can process [19].
The detection of recent positive selection seems ame-
nable to deep learning approaches, where learning to rec-
ognize features in raw SNP data, such as the length and 
shape of shared haplotypes in genes with known sweeps 
within and between populations, may help to identify 
sweeps across the genome. The work presented applies a 
deep learning image-classification approach, which does 
not require prior extraction or selection of population-
genetic statistics, to classify selective sweeps from “hap-
lotypic” images. Using large P. falciparum (n = 1125) and 
P. vivax (n = 368) WGS datasets, partitioned into training 
and validation sets, the analysis shows that a deep learn-
ing approach (called “DeepSweep”) calibrates well with 
other haplotype-based methods and other studies, and 




DeepSweep is a deep learning model to detect instances 
of positive selection. It creates and analyses standard-
ized images of the nearby genomic region around a given 
SNP. In brief, for each SNP of interest, and across all iso-
lates, DeepSweep selects neighbouring SNPs at regularly 
spaced intervals, and subsequently sorts the remaining 
genomic matrix in alignment with the longest common 
haplotype, grouped for each population and for the ref-
erence and alternative alleles. The intuition is that SNPs 
that have undergone recent selective sweeps have a dif-
ferent haplotype structure resulting in distinct images 
(Additional file 1: Figure S1).
Page 3 of 9Deelder et al. Malar J          (2021) 20:270  
Model structure
DeepSweep uses a convolutional neural network (CNN) 
architecture, implemented using the Keras library (ver-
sion 2.2.4) [20] in Python. The model was based on the 
AlexNet Classifier architecture, widely used for image 
analysis [21]. Through optimization, it was aimed to fit 
the smallest sized model (in terms of number of trainable 
parameters) that showed good predictive performance 
with low validation loss and high validation accuracy, but 
also detected features of interest, avoided overfitting, and 
minimized computational burden. Informally, overfit-
ting is the training of a model that is too specifically tai-
lored to (artefacts in) the training dataset and does not 
generalize well to unseen data. Statistically, within the 
framework of the bias–variance trade-off of a model, 
overfitting occurs where there is excessive variance 
resulting from an algorithm modelling the random noise 
in the training data [22]. The approach optimized over 
various hyper-parameters, including the number of con-
volutional layers (ranging from 1 to 5 layers), the number 
of filters (ranging from 2 to 96) and convolutional field 
sizes (ranging from 3 × 3 to 40 × 40). Regularization tech-
niques (e.g. dropout [22]) were applied to prevent over-
fitting and support transferability. The model was trained 
to reduce binary cross-entropy between actual labels 
and estimated probabilities on images of known- and 
non-sweeps. The model structure was validated for 500 
epochs. The final model has one convolutional layer, two 
dense layers, four convolutional filters, and a large con-
volutional field (40 × 9). The haplo-imaging algorithm 
and the machine learning analyses (Additional file  1: 
Figures  S1, S2) were conducted in Python (version 2.7). 
The core packages for the machine learning were SnpEff 
(for annotating effect size) [23], SnpSift (for filtering VCF 
files) [24], PyVCF (for adjusting and creating VCF files) 
[25], SciPy and matplotlib (for image manipulation) and 
Tensorflow (version 1.15).
Simulated data
Sequence data was generated using SFS_Code software 
[26], which is a forward population genetic simulator. 
Simulated data corresponded to four sweep types ((i) 
recent—strong; (ii) recent—weak; (iii) historic—strong; 
(iv) partial) and compared to a Wright-Fisher “neu-
tral” setting. The parameter settings are outlined (Addi-
tional file 1: Table S1), and lead to plausible scenarios for 
Plasmodium parasites [10]. For each comparison, 160 
simulated datasets (128 training; 32 validation) were gen-
erated, each dataset with 4 populations of 100 parasite 
sequences (50% sweep, 50% neutral) and a locus length 
of at least 1kbp, where the mutation under selection was 
in the centre of the region. For the combined analysis of 
the sweep types, 640 simulated datasets (512 training, 
128 validation) were used. These data were subsequently 
transformed into the aforementioned “haplotype images” 
that serve as input to the image classifier (Additional 
file  1: Figure S1). These haplo-images showed qualita-
tively discernible differences in features, with stronger or 
more recent sweeps leading to more “block-like” features 
(Additional file  1: Figure S3). The image classifier was 
trained on the simulated data, and classification accuracy 
and reduction of binomial loss were estimated. Simulated 
data was also used to illustrate the impact of changes in 
a subset of hyperparameters and confirmed that the final 
model had low validation loss and high validation accu-
racy (Additional file 1: Table S2).
Plasmodium sequencing data
Publicly available raw Illumina WGS data for P. falcipa-
rum (n = 1125) [27] and P. vivax (n = 368) [28], repre-
senting 11 malaria endemic countries (Additional file 1: 
Table S3; accession numbers in Additional file 1: Tables 
S4, S5). All samples were assessed by estMOI software 
[29] as either monoclonal or polyclonal samples with only 
a major dominant clone, to minimize the effects on anal-
ysis of multiplicity of infection. The P. falciparum and P. 
vivax sequences were mapped to the Pf3D7 (23Mbp) and 
PvP01 (29Mbp) reference genomes, respectively, using 
bwa-mem software (version 0.7.12; using default param-
eter settings) [30]. From the resulting alignments, SNPs 
and insertions and deletions (indels) were called from the 
consensus of GATK (version 4.1.4.1) [31] and samtools 
(version 1.9) [32] software (using default parameter set-
tings), as applied in previous studies [4, 10]. SNPs were 
retained if they had < 10% missing alleles and a minor 
allele count greater than 4. The resulting dataset com-
prised of parasite genomes of P. falciparum (1,125 iso-
lates, 74,757 SNPs) and of P. vivax (368 isolates, 126,596 
SNPs). The number of missing values was 1,179,202 
(2.9%) for P. vivax and 649,337 (1.2%) for P. falciparum. 
Missing alleles were imputed using the isolate with the 
longest shared haplotype around the missing position. 
An overview of the analytical approach is summarized 
(Additional file  1: Figure S2). The SnpEff tool (https:// 
pcing ola. github. io/ SnpEff/) was used to annotate SNP 
variants and predict their effects on genes.
For DeepSweep model training, the presumed posi-
tive examples of positive selection are regions sur-
rounding SNPs that are linked to drug resistance with 
an established scientific literature. For P. falciparum, 
these included regions around established SNPs in pfcrt 
(K76T, I356T; chloroquine), pfdhfr (N51I, C59R, S108N, 
I164L, S306F)/pfdhps (I431V, S436A, A437G, K540E/N, 
A581G, S613S) (SP), pfmdr1 (N86Y; mefloquine, chlo-
roquine), and pfkelch13 (F446I, Y493H, P574L, R539T, 
Page 4 of 9Deelder et al. Malar J          (2021) 20:270 
and C580Y; artemisinin) [27]. For P. vivax, these included 
regions around some known SNPs in pvdhps (A553G, 
G383A, S382C/A) / pvdhfr (N50I, F57I/L, S/K58R, 
T61M, N117T/S) (putative SP) and pvmdr1 (F1076L, 
Y976F, S698G, S513R; putative chloroquine) [4, 6]. This 
could be considered a relatively small number of training 
exemplars, which may lead to an increased risk that the 
implemented machine learning algorithm overfits due 
to potential artefacts in the training data. Therefore, for 
each Plasmodium species, “leave-one-group-out” cross-
validation was implemented to understand the influence 
of individual training genes, where each single gene of 
the positive training examples was omitted in turn, with 
the model trained on the remaining genes [33]. The final 
model was fit on 80% of the data (split by SNPs), with 
20% left as a hold-out set. The DeepSweep approach was 
compared to traditional haplotype-based statistics (iHS 




Across the 4 different types of sweep simulations, the 
predictive accuracy was highest for more recent strong 
selection (97.1%), followed by weak selection (96.8%) and 
historic selection (88.2%) and partial selection (86.7%) 
(Table 1, Additional file 1: Figure S4). The total sensitivity 
across all sweeps combined was 89.1%, with a specificity 
of 93.8%, and an overall classification accuracy of 91.4%. 
The areas under the ROC curve were high for all simu-
lations involving recent selection (> 0.95; maximum 1), 
consistent with the high predictive ability of DeepSweep. 
The simulation results showed the potential utility of the 
approach when combining data across populations with 
common sweeps at difference stages.
Plasmodium falciparum DeepSweep analysis
The dataset comprised of 1,125 isolates and 74,757 SNPs. 
Most of these SNPs are in genic regions (76.5%), with 
63.0% non-synonymous amino acid changes. Most SNPs 
have low minor allele frequencies (SNPs with MAF < 1%: 
94.6%) (Additional file 1: Figure S5). The image classifier 
was trained on regions covering the established resist-
ance SNPs in five genes, and found the models validated 
well using a leave-one-group-out approach. In particular, 
the overall accuracy was 83.6% (standard deviation 6.0%), 
where the performance was lower when pfdhfr was omit-
ted (75.0%) and was higher when pfdhps (92.3%) was left 
out. One interpretation is that pfdhfr is under stronger 
selection than pfdhps, which would be consistent with 
pfdhfr N51I, C59R, S108N, I164L and S306F mutations 
underpinning key haplotypes underlying SP resistance 
[37]. The final model was fitted on 80% of the data, with 
20% of the data used as a validation set, and demon-
strated a strong performance both in terms of classifica-
tion accuracy and reduction of binomial loss (Additional 
file 1: Figure S6). The trained classifier was then used to 
make predictions for the entire dataset of P. falciparum 
SNPs.
The deep learning model identified 387 SNPs in 160 
genes (or ~ 2.9% of genes) as putatively under positive 
selection pressure in the wider dataset (Fig.  1). Further 
analysis focused on the subset of 11 genes that have > 6 
hits (Table  2; see Additional file  1: Table  S6 for the 26 
genes with > 3 SNPs). Several peaks were in the vicinity 
of known drug-resistance genes in the training set, with 
nearby genes likely to be swept along (e.g. on pfdhfr on 
chromosome 4, pfmdr1 on chromosome 5, pfcrt on 
chromosome 7, pfdhps on chromosome 8 and pfkelch13 
on chromosome 13). There is an additional peak on 
chromosome 6 that includes Pk4 (PF3D7_0628200) 
and the HECT domain (PF3D7_0628100). Transcrip-
tion of Pk4 has been related to artemisinin-induced 
latency [38], and the HECT domain is thought to alter 
quinine and quinidine response, and likely co-selected 
with pfcrt [39]. There is a small peak on chromosome 10 
(PF3D7_1013500) in the close vicinity of the gene encod-
ing the autophagy-related protein 18 (PF3D7_1012900), 
which has been associated with artemisinin resistance. 
There is a peak on chromosome 12 (PF3D7_1223500) 
which has been putatively associated with SP resistance 
[40]. Smaller peaks were observed on chromosome 14 
around PF3D7_1462400, which has been associated with 
chloroquine resistance [41].
Plasmodium vivax DeepSweep analysis
The dataset comprised of 368 isolates and 126,596 SNPs. 
Most of these SNPs are in genic regions (77.6%), with 
42.5% non-synonymous amino acid changes. Many SNPs 
have low minor allele frequencies (SNPs with MAF < 1%: 
77.6%) (Additional file  1: Figure S5). The image classi-
fier was trained on the sixteen SNP mutations in the 
three genes. Using a leave-one-group-out validation 
approach, the overall accuracy was 79.7% (standard 
deviation 17.6%), and the performance was lower when 
Table 1 Model performance based on simulated data








Stronger selection—recent sweep 97.1 93.8 100 1
Stronger selection—historic sweep 88.2 93.8 83.3 0.858
Weaker selection—recent sweep 96.8 100 93.3 1
Partial sweep 86.7 87.5 85.7 0.951
All sweeps combined 91.4 89.1 93.8 0.944
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pvmdr1 was omitted (57.1%) and was higher when pvd-
hfr was left out (100%). This difference is consistent with 
pvmdr1 residues being strongly associated with chloro-
quine resistance [5] and, although, pvdhfr may contribute 
to SP drug resistance, there are very few published stud-
ies that associate genotypes of this locus with anti-folate 
susceptibility phenotypes [6]. As with P. falciparum, the 
trained model had strong performance both in terms of 
classification accuracy and reduction of binomial loss 
(Additional file  1: Figure S6). The model identified 577 
hits in 237 genes (or ~ 4.3% of genes) as putatively under 
positive selection pressure in the wider dataset (Fig.  1). 
Further analysis focused on the subset of 19 genes that 
have > 6 hits (Table  3; see Additional file 1: Table  S7 for 
the 35 genes with > 3 SNPs). Several loci are near the 
Fig. 1 Number of DeepSweep Hits per locus across the 14 
chromosomes and the relationship to the number of Rsb (top panel; 
blue line) and iHS (top panel; orange line) hits. a P. falciparum. Blue 
line is the running average of Rsb hits (p < 0.0001) over the nearest 
100 locations. The orange line is the running average of iHS hits 
(p < 0.0001) over the nearest 100 locations. The vertical blue lines 
indicate pfdhfr (Chr. 4: 749,001, pfmdr1 (Chr. 5: 960,020), pfcrt (Chr. 7: 
404,770), pfdhps (Chr. 8: 549,408); pfkelch13 (Chr. 13: 1,724,817). The 
tick-marks on the x-axis are chromosomal mid-points. b P. vivax. Top 
panel: Blue line is the running average of Rsb hits (p < 0.0001) over 
the nearest 100 locations. The orange line is the running average of 
iHS hits (p < 0.0001) over the nearest 100 locations. The vertical blue 
lines indicate pvdhfr (Chr. 5), pvmdr1 (Chr. 10), pvdhps (Chr. 14). The 
tick-marks on the x-axis are chromosomal mid-points
Table 2 Plasmodium falciparum loci identified by DeepSweep 
(DS; with > 6 SNPs)
Chr Chromosome; iHS and Rsb counts defined as the number of SNPs in a 
gene that have an |iHS| or |Rsb| score with a p-value < 0.0001; pfdhfr (Chr. 4: 
749,001, pfmdr1 (Chr. 5: 960,020), pfcrt (Chr. 7: 404,770), pfdhps (Chr. 8: 549,408; * 
previously identified; ** close to known gene
Chr Gene ID (PF3D7_) DS
hits
iHS hits Rsb hits
6 627800* 20 11 39
6 628100* 18 1 30
5 522400** 13 8
7 709100** 11 38
7 708200** 9 14
8 809600** 9 3 29
4 417400** 8 37
5 522900** 8
12 1223500* 8 11
7 709300** 7 46
8 811200** 7 11
Table 3 Plasmodium vivax loci identified by DeepSweep (DS; 
with > 6 SNPs)
Chr Chromosome, iHS and Rsb Counts defined as the number of SNPs in a gene 
that have an iHS or Rsb score with a p-value < 0.0001; pvdhfr (Chr. 5), pvmdr1 










5 526800** 19 4 12
11 1101300 14 2
14 1428700** 13 1 5
2 202000 11 4
7 709800 11 0
10 1011000** 11 1
14 1432900 11 1 1
5 526400** 10 1 12
7 701100 10 8
9 948800 10 5
5 526300** 9 2 4
10 1034400 9
12 1271500 8
2 203000* 7 33
9 939900 7 2 1
10 1033900 7
13 1317300 7 15
14 1418100 7 1
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training genes (pvdhfr on chromosome 5, pvmdr1 on 
chromosome 10, pvdhps on chromosome 14). Further, 
there was a peak around the gene encoding for the multi-
drug associated protein 1 (pvmrp1), which is a putative 
resistance candidate [4]. On chromosome 7, there was a 
peak around a gene coding for cysteine repeat modular 
protein 1, which is expressed in both vertebrate and mos-
quito hosts for host tissue targeting and invasion. This 
locus has been identified as presenting high population 
differentiation and under directional selective pressure 
in South America [4]. Finally, there was a larger region 
that was identified on chromosome 14, which contains 
pvdhps and a number of other genes that have been 
found in other analyses [4].
Comparison with established positive selection 
approaches
An analysis using the established REHH approach was 
performed, which involved the calculation of the inte-
grated haplotype score (iHS) within populations and 
the associated Rsb values between pairs of popula-
tions (Additional file  1: Tables S8, S9). Although the 
REHH and DeepSweep methods have a different rank-
ing of the strongest hits, there was an overall posi-
tive correlation between the number of hits from Rsb 
and DeepSweep (Pearson correlation: P. falciparum 
0.49, P. vivax 0.20; Additional file  1: Figure S7). How-
ever, DeepSweep detected several novel loci that were 
not identified by REHH. These included loci on chro-
mosomes 6 (PF3D7_0611800), 8 (PF3D7_0811600) 
and 14 (PF3D7_1461800) for P. falciparum (Additional 
file 1: Table S6), and on chromosomes 6 (PIR protein), 7 
(cysteine repeat modular protein) and chromosome 14 
for P. vivax (Additional file 1: Table S7). PF3D7_0611800 
has been linked to increased cytoadherence [42], 
PF3D7_0811600 has previously been linked to SP resist-
ance [40] and the genes coding for the PIR protein and 
the cysteine repeat protein have been associated with 
immune response and host invasion [43, 44]. There were 
several loci that were detected by EHH methods but not 
by DeepSweep (Additional file 1: Tables S8, S9). Some of 
the top hits included genes that are linked to immune 
response and host invasion (e.g. PF3D7_1133400 
AMA1, PF3D7_1335100 MSP7). Other hits are house-
keeping genes that are less likely to be under selective 
pressure (e.g. PF3D7_0731800 (alpha/beta hydrolase), 
PF3D7_1475900 (KELT protein), PVP01_0202900 (18S) 
and PVP01_1003700 (PPT)).
Discussion
The application of whole genome sequencing (WGS) 
is gaining traction across malaria endemic countries. 
With the resulting development of Plasmodium parasite 
genomic databases (“big data”), there is an opportunity 
for the implementation of machine learning methods to 
inform disease control. The detection of genomic sig-
natures of selective sweeps resulting from the spread of 
mutations associated with anti-malarial drug resistance is 
one application of WGS data. This work presents a super-
vised (deep) learning approach (DeepSweep), which after 
being trained on haplotypic “images” of established drug 
resistance genes in P. falciparum and P. vivax parasites, 
resulted in the identification of loci known to be under 
recent positive selection. Whilst the strength of sweep 
signals per locus found by DeepSweep correlated with 
established EHH methods (e.g. between population Rsb), 
the machine learning approach has the advantage of not 
requiring a rigid definition and calculation of population-
genetic statistics, incorporating information within and 
across populations, and relatively lower requirements for 
the pre-processing of raw SNP data. Like other machine 
learning approaches, it has the potential to scale up to 
large numbers of samples, and is parallelizable across 
genomic regions, thereby making it a potentially useful 
“big data” tool. In the absence of sufficient computational 
power, it is possible to develop sampling strategies that 
can select the subset of the data and samples that contain 
the highest density of information relevant to DeepSweep. 
Different model structures were assessed, but perfor-
mance could be improved by further fine tuning of model 
hyperparameters (e.g. the number and size of the convo-
lutional filters).
DeepSweep detected a set of loci not detected by the 
EHH methods, potentially because a deep learning 
approach can holistically incorporate information from 
the raw SNP data, which could be fragmented across 
separate populations and genomic windows, for the cal-
culation of population-genetic statistics. Indeed, the 
simulation study demonstrated the potential of including 
haplo-images with not only single, but multiple popula-
tions, to allow the algorithm to take advantage of fea-
tures that are common across regions and be robust to 
different stages of the sweeps. However, DeepSweep does 
require “representative” positive training examples, and 
in the context applied, assumes that the training drug 
resistance related loci have undergone or are undergo-
ing selective sweeps in some of the populations. This 
assumption is not unrealistic given that some antima-
larial drugs have been rolled out in different populations 
at different times resulting in differential stages of selec-
tive sweeps [40]. The DeepSweep and EHH approaches, 
as well as alternative methods (e.g. HaploPS [45]), can be 
considered complementary and could be run in parallel. 
However, as these approaches will increasingly use WGS, 
there are general challenges that affect variant-calling and 
ascertainment (e.g. extreme genome GC content), which 
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can impact on the density and accuracy of genomic vari-
ant inputs, as well as the final population genomic analy-
sis. Typically, WGS analysis leads to a dense set of well 
supported variants in robust genomic regions, with the 
application of calling algorithms incorporating informa-
tion on known high quality polymorphisms [6]. Further, 
highly variable or problematic regions, such as var genes 
in P. falciparum, are typically removed from analysis [46]. 
In general, DeepSweep appeared to perform well across 
different GC content settings (P. falciparum 19%, P. vivax 
58%), as well as in a simulated data setting which did not 
impose any constraint on GC content. However, in gen-
eral, it is important to evaluate the quality of genomic 
variants used in an analysis. A further consideration is 
that most approaches use haplotype data, which in the 
human context require phasing from genotypes. Whilst 
the Plasmodium life cycle involves haploid asexual stages, 
complex clinical infections can complicate and confound 
population genetic analyses, and therefore analysis was 
restricted to infections with a dominant clone. However, 
it may be possible to extend DeepSweep to process indi-
vidual parasite sequences for samples with multiplicity of 
infection. Irrespective, any novel loci identified should be 
confirmed through functional work [47]. Further, com-
plementary methods that look at isolate relatedness, as 
determined by identity by descent (e.g. IsoRelate [48]), 
could also be implemented. New loci detected by Deep-
Sweep that were not identified by other methods (e.g. on 
chromosomes 6, 8 and 14 for P. falciparum and on chro-
mosomes 6, 7 and 14 for P. vivax) provide interesting 
candidates for confirmation studies.
A potential future opportunity is to apply models 
across species, for example, to detect P. falciparum loci 
after being trained on P. vivax signatures, and vice-versa. 
Such an application could assist to detect regions where 
drug resistance loci are unknown or less established, such 
as P. vivax. However, the impacts of differences in sample 
size and degree of polymorphism between species need 
to be considered. Relatedly, “real data” was used for train-
ing, but an alternative may be to use coalescent or for-
ward-in-time simulation to create positive and negative 
labelled exemplars. However, there is a risk that images 
might not be representative of actual selective sweeps 
in nature. The deep learning algorithm has applications 
beyond positive selection, including for other evolution-
ary signatures (e.g. balancing selection) or application to 
other organisms (e.g. mosquitoes and humans).
Conclusions
The DeepSweep approach and the wider application 
of deep learning using genomic images constitutes a 
novel approach that shows promising results. It pro-
vides a robust, accessible and scalable approach for the 
identification of genomic regions under positive selec-
tion, and could assist with detecting established and new 
types of drug resistance. Thereby, providing insights into 
transmission dynamics and informing malaria control 
decision-making.
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